There are currently 167 ongoing clinical trials involving Gliosarcoma
Of the 167 trials,65 trials are in Phase II
Furthermore, 41 trials are in Phase I
The global pharmaceutical industry is steadily developing new drugs for Gliosarcoma, an oncology condition. The largest number of ongoing clinical trials for Gliosarcoma is conducted in North America. Asia-Pacific and Europe are among some of the other prominent regions engaged in Gliosarcoma-related drug trials.
National Cancer Institute US: The leading ongoing Gliosarcoma related clinical trial sponsor
National Cancer Institute US is the top sponsor for Gliosarcoma-related ongoing clinical trials.
Adult Brain Tumor Consortium, Dana-Farber Cancer Institute Inc, Dana-Farber/Harvard Cancer Center, and Sidney Kimmel Comprehensive Cancer Center are among other notable clinical trial sponsors involved in Gliosarcoma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer